We’ve seen this before with hydroxychloroquine. Whenever a study comes out that shows no benefit, we get the No True Scotsman argument: - Dose was too low/high - Started too early/late - Not combined/shoulda been combined with <insert drug> - Not THESE patients! Etc etchttps://twitter.com/BIRDGroupUK/status/1425880281618190337 …
The confidence intervals in the trial range from benefit to detriment. A very technical reading would be that the trial demonstrated that ivermectin may cause anything from reductions in deaths to increases in fatality, but it's not unfair to shorten that to no effect
-
Show additional replies, including those that may contain offensive content
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

